39th Annual Meeting & Pre-Conference Programs

Nov. 6–10, 2024 | Houston, TX | #SITC24

April 2024

Abstract submissions open

May 2024

Registration opens

July 2024

Regular & YIA abstracts close

Advance the science, discover breakthroughs and educate the world on cancer immunotherapy.


Share your latest research with cancer immunotherapy leaders.


Learn how the latest immuno-oncology science can better treat your patients.


Network with international leaders from academia and government.

Early Career Scientists

Meet established leaders in the cancer immunotherapy field.

Save the Date

Thank you for your interest in SITC's 39th Annual Meeting & Pre-Conference Programs in Houston, TX from Nov. 6-10, 2024 at the George R. Brown Convention Center.

Sign up to get the latest SITC 2024 information on registration, abstracts, sponsorship and exhibiting opportunities.

Thank you to our SITC 2024 Organizers

Harriet Kluger, MD
Annual Program Committee Chair

Harriet Kluger, MD

Yale University

Miriam Merad, MD, PhD
Annual Program Committee Co-Chair

Miriam Merad, MD, PhD, FAIO

Icahn School of Medicine at Mount Sinai

Yvonne Chen, PhD
Annual Meeting Organizer

Yvonne Chen, PhD

University of California, Los Angeles

Alfred L. Garfall, MD
Annual Meeting Organizer

Alfred L. Garfall, MD

Perelman School of Medicine, University of Pennsylvania

Mary Kate Kasler, DNP
Annual Meeting Organizer

Mary Kate Kasler, DNP

Memorial Sloan Kettering Cancer Center

Aurélien Marabelle, MD, PhD
Annual Meeting Organizer

Aurélien Marabelle, MD, PhD

Gustave Roussy

Charles Swanton, MD, PhD, FRCP, FRS
Annual Meeting Organizer

Charles Swanton, MD, PhD, FRCP, FRS

Francis Crick Institute

Why Attend SITC 2024?

SITC 2024 provides a multidisciplinary educational and interactive environment focused on improving outcomes for cancer patients by incorporating strategies based on basic and applied cancer immunotherapy. The Annual Meeting consists of cutting-edge research presentations by experts in the field, oral and poster abstract presentations and ample opportunity for structured and informal discussions, including important networking opportunities. SITC 2024 also includes updates on major national and international initiatives from academia, government and industry, as well as important society projects.

The audience includes basic and clinical investigators from academic institutions, industry and regulatory agencies, including clinicians, basic and translational researchers, graduate students, post-doctoral fellows, and allied health professionals involved in cancer research as well as pharmacists and payers, who wish to learn more about cancer immunology and immunotherapy and its incorporation into current (and future) effective cancer treatment.

An Invitation to Exhibit at SITC's 39th Annual Meeting

Advancing the Science and Application of Cancer Immunotherapy Worldwide

Make your mark at the largest cancer immunotherapy conference and exhibit at SITC’s 39th Annual Meeting, hosted by the leading member-driven organization focused on cancer immunotherapy, SITC. At SITC’s Annual Meeting, we will bring together international leaders from academia, regulatory and government agencies, as well as industry representatives for unmatched education, scientific exchange and networking with the scientists driving the field.

If you have a product or service that will advance research or accelerate laboratory results, do not miss this opportunity to exhibit at SITC’s 39th Annual Meeting.

Reservations for returning 2023 exhibitors will open March 2024. New exhibitors can begin applying in April. Contact development@sitcancer.org to receive the most up to date information.

Exhibit Hall

Who Exhibits at SITC?

Biotechnology companies, cancer organizations/foundations, consulting groups, data management companies, informatics/analysis firms, medical device manufacturers, medical equipment suppliers, medical publishers, pharmaceutical companies, research companies/agencies, scientific supply companies, universities/hospitals/research institutions.

Exhibit Hall Group

Hybrid Exhibits

Each face-to-face exhibit booth includes an optional virtual booth space to connect with registrants who cannot attend in person. Take advantage of this space to network with attendees, feature resources and publications, highlight posters and symposia, and link to your company website.

Exhibit Hall Group

Get in touch

Contact our Development Team to learn more about exhibiting and/or sponsorship opportunities at SITC 2024. Please email us at development@sitcancer.org and we will be in touch as soon as possible. We hope to see you in Houston!